Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28872748 | 0.97 | MAPK1 (0.38) | MAPK1ALDH1A1 | |
| SCHEMBL13672646 | 0.75 | MAPK1 (0.36) | MAPK1ALDH1A1 | |
| SCHEMBL6673656 | 0.75 | TSHR (0.43) | ALDH1A1 | |
| SCHEMBL7812132 | 0.75 | MAPK1 (0.32) | MAPK1 | |
| SCHEMBL7051974 | 0.73 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL9329687 | 0.72 | ALDH1A1 (0.44) | ALDH1A1 | |
| SCHEMBL754497 | 0.72 | MAPK1 (0.36) | MAPK1ALDH1A1 | |
| SCHEMBL12433234 | 0.72 | MAPK1 (0.36) | MAPK1ALDH1A1 | |
| SCHEMBL823099 | 0.72 | CYP2C19 (0.38) | MAPK1ALDH1A1 | |
| SCHEMBL23126606 | 0.71 | MAPK1 (0.33) | MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107001213-B | Preparation method and purification method of organic compound with fluorinated aliphatic group | 财团法人峨山社会福祉财团 | 2021-01-15 | — | — | CN | claimed |
| EP-3216780-B1 | METHOD FOR PREPARING ORGANIC FLUORIDE-ALIPHATIC COMPOUND AND METHOD FOR PURIFYING ORGANIC FLUORIDE-ALIPHATIC COMPOUND | ASAN FOUND (KR) | 2020-10-07 | — | — | EP | claimed |
| CN-111574515-A | Preparation method and purification method of organic fluorinated aliphatic compound | 财团法人峨山社会福祉财团 | 2020-08-25 | — | — | CN | claimed |
| US-20170319720-A1 | METHOD FOR PREPARING ORGANIC FLUORIDE-ALIPHATIC COMPOUND AND METHOD FOR PURIFYING ORGANIC FLUORIDE-ALIPHATIC COMPOUND | Ackerman, Christopher (PR) | 2017-11-09 | — | — | US | claimed |
| EP-3216780-A1 | METHOD FOR PREPARING ORGANIC FLUORIDE-ALIPHATIC COMPOUND AND METHOD FOR PURIFYING ORGANIC FLUORIDE-ALIPHATIC COMPOUND | The Asan Foundation (KR) | 2017-09-13 | — | — | EP | claimed |
| CN-107001213-A | Preparation method and purification method of organic fluorinated aliphatic compound | 财团法人峨山社会福祉财团 | 2017-08-01 | — | — | CN | claimed |
| CN-119998260-A | Process for preparing amides from esters | 巴斯夫欧洲公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-111801313-B | Method for preparing polymorphic form B of treprostinil diethanolamine salt | 奇诺因药物和化学工厂私人有限公司 | 2023-08-29 | — | — | CN | disclosed |
| US-20230219956-A1 | QUINAZOLINE COMPOUND AND PHARMACEUTICAL APPLICATION THEREOF | BETTA PHARMACEUTICALS CO.,LTD (CN) | 2023-07-13 | — | — | US | disclosed |
| US-20230159504-A1 | 7- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD) | VERTEX PHARMACEUTICALS INCORPORATED | 2023-05-25 | — | — | US | disclosed |
| CN-111574515-B | Preparation method and purification method of organic fluorinated aliphatic compound | 财团法人峨山社会福祉财团 | 2023-01-10 | — | — | CN | disclosed |
| EP-3521247-B1 | FLAKE-LIKE MESOPOROUS PARTICLES AND MANUFACTURING METHOD THEREFOR | NIPPON SHEET GLASS CO LTD (JP) | 2022-01-26 | — | — | EP | disclosed |
| CN-107001213-B | Preparation method and purification method of organic compound with fluorinated aliphatic group | 财团法人峨山社会福祉财团 | 2021-01-15 | — | — | CN | disclosed |
| EP-0920430-B1 | PURINE DERIVATIVES AND THEIR USE AS ANTI-COAGULANTS | SCHERING AG (DE) | 2003-09-24 | — | — | EP | disclosed |
| US-20020165218-A1 | Materials and methods to potentiate cancer treatment | LUITPOLD PHARMACEUTICALS, INC. | 2002-11-07 | — | — | US | disclosed |
| US-20020131932-A1 | Radiopharmaceuticals for diagnosing alzheimer's disease | SCHERING AG (DE) | 2002-09-19 | — | — | US | disclosed |
| US-6313060-B1 | Catalyst for ring-opening polymerization of alkylene oxide, method for preparation thereof and use thereof | ASAHI GLASS COMPANY, LIMITED (JP) | 2001-11-06 | — | — | US | disclosed |
| EP-1022300-A1 | CATALYST FOR RING-OPENING POLYMERIZATION OF ALKYLENE OXIDE, METHOD FOR PREPARATION THEREOF AND USE THEREOF | ASAHI GLASS COMPANY LTD. (JP) | 2000-07-26 | — | — | EP | disclosed |
| US-5750640-A | FUEL ADDITIVES | SHELL OIL COMPANY (US) | 1998-05-12 | — | — | US | disclosed |
| US-5546108-A | Ink-jet type recorder having an ink carrier and letting ink by combined heat and eletrostatic force | MINOLTA CAMERA KABUSHIKI KAISHA (JP) | 1996-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170319720-A1 | METHOD FOR PREPARING ORGANIC FLUORIDE-ALIPHATIC COMPOUND AND METHOD FOR PURIFYING ORGANIC FLUORIDE-ALIPHATIC COMPOUND | AFF1, OSBP, GBA1 | MAPK1 1267/4885ALDH1A1 532/4885 |
| US-20020131932-A1 | Radiopharmaceuticals for diagnosing alzheimer's disease | CCR1, CCR3, CCR2 | MAPK1 2953/4885ALDH1A1 852/4885 |
| US-20230219956-A1 | QUINAZOLINE COMPOUND AND PHARMACEUTICAL APPLICATION THEREOF | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, ABCG2, NQO2 | MAPK1 4096/4885ALDH1A1 2410/4885 |
| US-20020165218-A1 | Materials and methods to potentiate cancer treatment | DCK, CHEK2, CHEK1 | MAPK1 1347/4885ALDH1A1 3519/4885 |
| US-20230159504-A1 | 7- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD) | SERPINA2, SERPINB1, SERPINE1 | MAPK1 1773/4885ALDH1A1 542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.